←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Trials, Biomarker Trial Design
Brian M. Alexander
MD, MPH
🏢Foundation Medicine🌐USA
Chief Medical Officer
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Brian Alexander serves as CMO at Foundation Medicine and has led adaptive platform trial design in glioblastoma including GBM AGILE. His work has advanced biomarker integration in master protocols and regulatory frameworks for companion diagnostics. He has shaped contemporary biomarker trial methodology.
Share:
🧪Research Fields 研究领域
adaptive platform trials
GBM AGILE
glioblastoma
biomarker trials
companion diagnostics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Brian M. Alexander 的研究动态
Follow Brian M. Alexander's research updates
留下邮箱，当我们发布与 Brian M. Alexander（Foundation Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment